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Background: In addition to increasing the risk of adverse birth outcomes, diabetes in pregnancy is thought to be
an important driver of the epidemic of type 2 diabetes affecting Canada’s First Nations population. The relative
contributions of gestational diabetes mellitus (GDM) and pre-existing diabetes are not well understood. We
generated a comprehensive epidemiological profile of diabetes in pregnancy over a 10-year period among
the First Nations population of Alberta, Canada.
Methods: De-identified administrative data for 427,058 delivery records were obtained for the years 2000–2009.
Pregnancy risk factors and delivery outcomes were described and compared by ethnicity (First Nations vs. non-First
Nations) and diabetes status. Age-adjusted prevalence values for GDM and pre-existing diabetes were calculated
and were compared by ethnicity. Longitudinal changes over time were also examined. Predictors were explored
using logistic regression analysis.
Results: First Nations women had more antenatal risk factors and adverse infant outcomes that were compounded by
diabetes. First Nations descent was an independent predictor of diabetes in pregnancy (p < 0.001). GDM prevalence
was significantly higher among First Nations (6.1%) compared to non-First Nations women (3.8%; p < 0.001), but
prevalence values increased significantly over time only in non-First Nations women (4.5 average annual percent
change; p < 0.05). The prevalence of pre-existing diabetes was stable over time in both groups, but First Nations
women experienced a 2.5-fold higher overall prevalence compared with non-First Nations women (1.5% vs.
0.6%, respectively; p < 0.001).
Conclusions: Although First Nations women experience a higher overall prevalence of diabetes in pregnancy,
the lack of increase in the prevalence over time is encouraging. However, because high-risk pregnancies and
poor outcomes are more common among First Nations women, particularly those with diabetes, strategies to
improve perinatal care must be implemented.
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Diabetes in pregnancy [i.e., pre-existing diabetes and
gestational diabetes mellitus (GDM)] is a major risk fac-
tor for perinatal complications, future obesity, and type
2 diabetes in mothers and their offspring [1-3]. This re-
lationship is particularly strong if blood sugar remains
unmanaged. Consequently, diabetes in pregnancy is con-
sidered to be a key predictor of, and contributor to, the* Correspondence: roster@ualberta.ca
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unless otherwise stated.current increases in type 2 diabetes worldwide, particu-
larly in Indigenous populations [4]. Prevalence and inci-
dence of type 2 diabetes has increased rapidly in Canada’s
most populous Indigenous group (the First Nations) over
the past half century and are currently 2–5 times greater
than in the general Canadian population [5-7]. First Na-
tions women generally suffer from a higher type 2 diabetes
prevalence compared with their male counterparts [4,6-8].
Pregnancy may be a crucial point for interventions
and appropriate healthcare aimed at reducing the preva-
lence of type 2 diabetes in First Nations peoples [2,9-11].
However, insufficient awareness and gaps in a detailedtd. This is an Open Access article distributed under the terms of the Creative
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uting to the lack of progress in reversing the epidemic.
Knowledge about the extent of the problem of diabetes in
pregnancy among First Nations women (namely preva-
lence, longitudinal trends in prevalence, and predictors of
diabetes) is based primarily on cross-sectional studies fo-
cusing on crude GDM prevalence. Longitudinal data and
data on pre-existing diabetes in pregnancy are limited.
Other important maternal factors and pregnancy out-
comes related to GDM and pre-existing diabetes in preg-
nancy have yet to be explored in this population. These
factors and outcomes include the presence of pregesta-
tional hypertension, proteinuria or anemia, and smoking,
alcohol consumption, illicit drug use, prior obstetrical his-
tory, breastfeeding, neonatal intensive care unit (NICU)
admission, and preterm delivery. For these reasons, the
current study was designed to use provincial administra-
tive data to generate an epidemiological profile of First
Nations diabetes in pregnancy in the province of Alberta.
Methods
Data
The Human Research Ethics Board of the University of
Alberta approved the research protocol. Each province
in Canada has different and separate procedures for col-
lecting perinatal data. The Alberta Perinatal Health Pro-
gram (APHP) comprehensively collects perinatal data
from the provincial delivery record for all hospital births
and registered midwife-attended home births. Delivery
record information is recorded by a healthcare provider
(usually a nurse) when a woman presents for delivery.
This information is obtained from prenatal records and/
or from the patient. Surveillance reports derived from
Alberta delivery records and APHP data are also pub-
lished [12]. Pertinent de-identified data from all deliv-
ery records were requested for the years 2000–2009
(complete data for 2010 and later were not available at
the time of the request). Data from multiple pregnan-
cies were included in the request. Data were complete
or nearly complete (available for 97%–100% of preg-
nancies) for the majority of the variables.
During the time period of the obtained data, GDM diag-
nosis followed Canadian Diabetes Association guidelines
[13]. Diagnosis included screening at 24–28 weeks with an
initial 50-g oral glucose challenge and a subsequent blood
glucose measurement at 1 hour post-consumption. A
result of < 7.8 mmol L−1 was considered to be a normal
result. A result of ≥ 10.3 mmol L−1 was considered to
indicate the presence of GDM. A subsequent 75-g oral
glucose tolerance test for the potential diagnosis of
GDM was indicated to follow up a result between 7.8–
10.2 mmol L−1. Two separate values of either fasting
glucose ≥ 5.3 mmol L−1, a 1-hour post-consumption
glucose ≥ 10.6 mmol L−1, or a 2-hour post-consumptionglucose ≥ 8.9 mmol L−1 confirmed a diagnosis of GDM
[13]. The presence of specific risk factors (e.g., previous
diagnosis of GDM or delivery of a macrosomic infant,
member of a high risk population, age > 35, obesity, poly-
cystic ovarian syndrome, acanthosis nigricans, or cortico-
steroid use) was a clinical indication for the performance
of glucose testing in the first trimester. A positive result
indicated the presence of “overt diabetes” (usually pre-
viously unrecognized or undiagnosed type 2 diabetes)
[13,14], which would have been recorded as pre-existing
diabetes. A diagnosis of pre-existing diabetes was other-
wise made from an assessment of patient history, clinical
chart records, and medication records (insulin or oral
antihyperglycemic agents). We were unable to discern
which pre-existing diabetes cases were type 1 diabetes and
which were type 2 diabetes. Descriptions of the other vari-
ables included in the analyses are presented in Additional
file 1. Because data on breastfeeding were available for just
33% (i.e., not for the entire province) of the pregnant
mothers, these data were used only for descriptive pur-
poses and were not included in the regression models.
The delivery records included calculation of a composite
antepartum risk score, which was a weighted summary
measure of pregnancy risk factors (45-item score of
pre-pregnancy, previous obstetrical history, problems
in current pregnancy and other risk factors). Women
that received a score ≥ 7 were considered to have high
risk pregnancies. The variables used and the scoring
details are available from the APHP [12]. They were
used in a recent retrospective study that assessed the
association between the Alberta antepartum risk score
and perinatal morbidity outcomes [15].
Population
The three types of Indigenous peoples recognized by
Canada are the First Nations, the Métis (mixed heritage),
and the Inuit peoples. Each group possesses distinct cul-
tural identities and has distinct governance and health-
care systems. First Nations and Inuit individuals whose
Nations have engaged in Treaties are accorded “regis-
tered Indian” or Treaty status, which includes a “status
card” that confers a number of Treaty rights, including
access to healthcare services. The Alberta Health Care
Insurance Plan Central Stakeholder Registry file [Minis-
try of Alberta Health (AH), Surveillance Division] in-
cludes an identifier for individuals with registered Indian
status. Data obtained from the APHP were sent to AH
for matching via the Personal Health Number. First Na-
tions individuals were defined as any Alberta resident
registered under the Indian Act of Canada and entitled
to Treaty status with the Canadian Government. A woman
with a First Nations identifier (i.e., First Nations or Inuit)
was classified as “First Nations” if her infant was delivered
in Alberta. Other persons recognized by Canada (e.g., the
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(such as First Nations individuals without Treaty status),
were included in the general population comparison group
because they could not be identified in the administrative
database. In Alberta, there are approximately 116,670 First
Nations people (19,945 of these are non-registered) and
96,865 Métis people, representing approximately 3.3% and
2.7% of the total population, respectively [16]. Very few
Inuit people (approximately 1,600) reside in Alberta. The
complete set of de-identified data was returned by AH in
STATA statistical software (StataCorp LP, College Station,
TX, USA) format.
Statistical analyses
All analyses were performed using STATA (version 11)
and Joinpoint (version 3.5.1, Rockville, Maryland, USA)
statistical software. P-values < 0.05 were considered to be
statistically significant. The prevalence and mean values
for maternal characteristics, pre-existing maternal risk
factors, problems with the current pregnancy, maternal
outcomes, and newborn outcomes were calculated. Preva-
lence calculations were completed separately for the fol-
lowing groups: all First Nations pregnancies without
diabetes, all non-First Nations pregnancies without dia-
betes, all First Nations pregnancies with diabetes, all non-
First Nations pregnancies with diabetes, all First Nations
pregnancies with pre-existing diabetes, and all First Na-
tions pregnancies with GDM. For the prevalence calcu-
lations, the denominator was the total number of
pregnancies where data on that variable were available
for the specific group of interest. The numerator was
the total number of pregnancies for which the criteria
for the variable of interest was met, for the specific
group of interest. Comparisons were by ethnicity (First
Nations vs. non-First Nations) among individuals with-
out diabetes and individuals with diabetes. Differences
between First Nations women with and without dia-
betes were also estimated. Finally, comparisons by dia-
betes type (GDM vs. pre-existing diabetes; type 1 and
type 2 diabetes combined) were made among First Na-
tions women with diabetes alone. Chi-square analysis
(for categorical variables) and t-tests (for continuous
variables) were used for the comparisons.
Our primary focus was to examine trends in, and risk
factors for, diabetes in pregnancy. Annual age-adjusted
prevalence of GDM and pre-existing diabetes for the en-
tire province by ethnicity were calculated using the dir-
ect method. Maternal age distribution data for the total
number of pregnancies in 2005 were obtained from
Canadian Vital Statistics [17] and were used as the refer-
ence population for age-adjustment. Crude prevalence
values were also calculated for comparison with results
from previous studies. For the longitudinal analyses (i.e.,
examination of changes in trends over time), the averageannual percent change (AAPC) in GDM and pre-existing
diabetes prevalence values over time were computed and
were compared between ethnic groups. The AAPC pro-
vided a summary measure of the trend over a pre-
specified fixed interval (2000–2009). Tests of parallelism
were then performed to determine whether trends over
time differed by ethnic group.
Multivariable logistic regression modeling (purposeful)
was used to evaluate the relationships between GDM
and potential explanatory variables (i.e., pre-existing ma-
ternal risk factors, past obstetrical variables, problems
with current pregnancy). The logistic regression analysis
was repeated using pre-existing diabetes as the dependent
variable. Briefly, independent variables with a p-value <
0.20 in the univariate linear regression analysis were fitted
in a multivariable model. Variables with a p-value > 0.05
were removed, and the potential confounding effect of
each variable was assessed. The linear assumptions of con-
tinuous variables and potential interaction effects were
assessed. The Hosmer–Lemeshow test was used to deter-
mine the model goodness-of-fit.
Results
The data received from the APHP indicated that there
were 433,445 pregnancies in Alberta between 2000
and 2009. Records where diabetes data were missing
(n = 6,387) were not included in the analyses. Of the
427,058 pregnancy records that were examined, 28,306
(6.6%) were from First Nations women. Results for the
number of pregnancies where diabetes data were avail-
able by year, age group, and ethnicity are presented in
Additional file 2. The majority (52.3%) of First Nations
pregnancies were among women < 25 years of age.
Only 22.5% of non-First Nations women were from
this age group.
The results for ethnicity comparisons for selected ma-
ternal characteristics, antenatal risk factors, and pregnancy
outcomes are presented in Table 1. Between-group com-
parisons (First Nations vs. non-First Nations) were made
among women with and without diabetes during preg-
nancy. For the majority of the comparisons, First Nations
women tended to have more risk factors and poorer out-
comes than non-First Nations women. This result sug-
gests that, overall, First Nations women have higher-risk
pregnancies. This is indicated most clearly by the elevated
prevalence of a composite antepartum risk score of ≥ 7
among First Nations women compared with non-First Na-
tions women. However, First Nations women had less
pregnancy-induced hypertension, and fewer labor induc-
tions, NICU admissions, and cesarean sections. Most of
these differences by ethnicity persisted when only preg-
nancies affected by diabetes were compared.
The results for the within-group comparisons among First
Nations women (women without diabetes in pregnancy vs.
Table 1 Selected maternal characteristics, antenatal risk factors, and pregnancy outcomes, by ethnicity and diabetes in
pregnancy status, Alberta, Canada, 2000–2009 (n = 427,058)
Women without diabetes (n = 407,855) Women with diabetes (n = 19,173)
First Nations
(n = 26,793)
Non-First Nations
(n = 381,092)
P-value First Nations
(n = 1,513)
Non-First Nations
(n = 17,660)
P-value
Maternal characteristics and risks
Age (years) 24.7 (5.8) 28.7 (5.5) <0.001 28.9 (6.2) 31.6 (5.3) <0.001
Rural 51.8 (51.2-52.4) 15.9 (15.8-16.0) <0.001 52.5 (49.9-55.0) 11.4 (10.9-11.9) <0.001
Weight≥ 91 kg 10.8 (10.5-11.2) 8.0 (7.9-8.1) <0.001 31.7 (29.3-34.1) 18.4 (17.9-19.0) <0.001
Pre-existing hypertension 0.9 (0.8-1.0) 0.9 (0.9-1.0) 0.367 4.2 (3.3-5.4) 3.3 (3.0-3.5) 0.041
Pregnancy induced hypertension 4.4 (4.2-4.7) 5.7 (5.6-5.7) <0.001 8.1 (6.7-9.7) 12.2 (11.7-12.7) 0.193
Proteinuria 2.4 (2.2-2.6) 1.9 (1.9-2.0) <0.001 5.6 (4.5-6.9) 3.9 (3.9-4.2) 0.001
Anemia 2.3 (2.1-2.5) 0.6 (0.5-0.6) <0.001 1.3 (0.8-2.0) 0.5 (0.4-0.7) <0.001
Smoker 54.7 (54.1-55.3) 17.0 (16.9-17.2) <0.001 49.4 (46.8-51.9) 14.3 (13.8-14.8) <0.001
Alcohol anytime 10.4 (10.0-11.0) 1.7 (1.5-1.8) <0.001 7.8 (6.2-9.8) 1.0 (0.8-1.1) <0.001
Drug dependant 6.6 (6.3-6.9) 0.9 (0.8-0.9) <0.001 3.5 (2.6-4.6) 0.4 (0.3-0.5) <0.001
Antepartum risk≥ 7 10.4 (10.1-10.8) 5.1 (5.1-5.2) <0.001 30.7 (28.4-33.1) 19.8 (19.2-2.4) <0.001
Pregnancy Outcomes
Induction of labour 23.8 (23.1-24.3) 27.3 (27.1-27.4) <0.001 41.7 (39.2-44.2) 40.9 (40.2-41.7) 0.554
Cesarean section 19.1 (18.6-19.5) 25.5 (25.4-25.6) <0.001 35.4 (33.0-37.8) 39.8 (39.0-40.9) 0.001
Low birth weight 8.0 (7.6-8.3) 7.1 (7.0-7.2) <0.001 7.2 (6.0-8.6) 8.6 (8.2-9.0) 0.063
High birth weight 16.7 (16.3-17.2) 11.1 (10.9-11.1) <0.001 29.3 (27.0-31.6) 12.9 (12.4-13.4) <0.001
Breastfeeding 71.2 (70.5-72.8) 88.3 (88.2-88.6) <0.001 74.7 (69.3-79.6) 86.3 (85.4-87.1) <0.001
Preterm 9.2 (8.9-9.6) 8.8 (8.7-8.9) 0.026 17.3 (15.4-19.3) 14.7 (14.2-15.3) 0.008
Stillbirth 1.2 (1.1-1.3) 0.7 (0.6-0.7) <0.001 2.1 (1.5-2.9) 0.6 (0.5-0.8) <0.001
Congenital anomaly 1.8 (1.6-2.0) 1.5 (1.4-1.5) 0.001 1.4 (0.8-2.3) 1.7 (1.5-2.1) 0.243
Neonatal intensive care unit admission 8.6 (8.3-9.0) 11.2 (11.1-11.3) <0.001 16.7 (14.8-15.7) 19.4 (18.8-20.0) <0.001
Data presented are mean (standard deviation) or percentage (95% confidence intervals).
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women with pre-existing diabetes) are presented in Table 2.
Compared with women without diabetes, women with dia-
betes tended to have more pregnancy-related risk factors, in-
cluding higher composite antepartum risk scores and poorer
outcomes. Compared with women with GDM, women with
pre-existing diabetes were significantly more likely to have
pre-existing risk factors (weight ≥ 91 kg, hypertension),
higher composite antepartum risk scores, and adverse infant
outcomes (preterm neonate, stillbirth, congenital anomaly,
and cesarean section).
The overall crude and age-adjusted GDM prevalence
values were significantly elevated for First Nations women
compared with non-First Nations women. The First Na-
tions to non-First Nations rate ratio was higher after age-
adjustment (Table 3). Similarly, First Nations women had
a higher prevalence of crude and age-adjusted pre-existing
diabetes than non-First Nations women for all of the years
included in the analysis (Table 3). Age-adjustment also re-
sulted in a greater rate ratio between ethnicities for this
comparison.During 2000 to 2009, age-adjusted GDM prevalence
increased significantly only among non-First Nations
women (Figure 1; p = 0.02 for the between-ethnicity dif-
ference in AAPC). The AAPC for GDM was 1.51 [95%
confidence interval (CI): −2.04–5.20; p = 0.20] among
First Nations women and 4.48 (95% CI: 2.88–6.11; p = 0.01)
among non-First Nations women. Prevalence of pre-
existing diabetes did not increase over time among ei-
ther First Nations or non-First Nations women, and
there were no between-group differences (Figure 1; p = 0.95
for the difference in AAPC between ethnicities). The
AAPCs for pre-existing diabetes were 1.55 (95% CI: −6.68–
8.19; p = 0.32) among First Nations women and 1.35 (95%
CI: −0.38–3.12; p = 0.18) among non-First Nations women.
Figure 2 presents the results for prevalence of age-
specific diabetes in pregnancy by ethnicity over the en-
tire time period. GDM prevalence was lowest for both
groups among women aged 15–19 years and increased
with increasing age. Pre-existing diabetes prevalence
values were considerably higher among First Nations
women aged 30–34 years and 35–39 years, which is
Table 2 Selected maternal characteristics, antenatal risk factors, and pregnancy outcomes for First Nations
pregnancies, by diabetes in pregnancy status and type, Alberta, Canada, 2000–2009 (n = 28,306)
Women without
diabetes (n = 26,793)
Women with
diabetes (n = 1,513)
P-value Women with pre-existing
diabetes (n = 289)
Women with GDM
(n = 1,224)
P-value
Maternal characteristics
and risks
Age (years) 24.7 (5.8) 28.9 (6.2) <0.001 29.2 (6.03) 28.8 (6.27) 0.407
Rural 51.8 (51.2-52.4) 52.5 (49.9-55.0) 0.614 55.4 (49.43-61.18) 51.8 (48.96-54.63) 0.275
Weight≥ 91 kg 10.8 (10.5-11.2) 31.7 (29.3-34.1) <0.001 37.0 (31.44-42.87) 30.4 (27.85-33.08) 0.030
Pre-existing
hypertension
0.9 (0.8-1.0) 4.2 (3.3-5.4) <0.001 9.3 (6.25-13.30) 3.0 (2.14-4.14) <0.001
Pregnancy induced
hypertension
4.4 (4.2-4.7) 8.1 (6.7-9.7) <0.001 10.0 (6.82-14.09) 11.3 (9.56-13.18) 0.545
Proteinuria 2.4 (2.2-2.6) 5.6 (4.5-6.9) <0.001 7.6 (4.83-11.30) 5.2 (3.98-6.54) 0.102
Anemia 2.3 (2.1-2.5) 1.3 (0.8-2.0) 0.013 0.7 (0.08-2.48) 1.5 (0.87-2.31) 0.297
Smoker 54.7 (54.1-55.3) 49.4 (46.8-51.9) <0.001 48.1 (42.21-54.02) 49.7 (46.83-52.51) 0.630
Alcohol anytime 10.4 (10.0-11.0) 7.8 (6.2-9.8) 0.001 6.9 (3.71-12.33) 7.9 (6.15-10.08) 0.285
Drug dependant 6.6 (6.3-6.9) 3.5 (2.6-4.6) <0.001 4.9 (2.69-8.05) 3.2 (2.25-4.32) 0.155
Antepartum risk≥ 7 10.4 (10.1-10.8) 30.7 (28.4-33.1) <0.001 47.1 (41.19-52.99) 26.9 (24.41-29.46) <0.001
Pregnancy Outcomes
Induction of labour 23.8 (23.1-24.3) 41.7 (39.2-44.2) <0.001 33.6 (28.14-39.33) 43.6 (40.83-46.46) 0.002
Cesarean section 19.1 (18.6-19.5) 35.4 (33.0-37.8) <0.001 46.7 (40.85-52.65) 32.7 (30.06-35.39) <0.001
Low birth weight 8.0 (7.6-8.3) 7.2 (6.0-8.6) 0.308 9.0 (5.96-12.90) 6.8 (5.45-8.35) 0.193
High birth weight 16.7 (16.3-17.2) 29.3 (27.0-31.6) <0.001 26.3 (21.32-31.77) 30.0 (27.39-32.61) 0.220
Breastfeeding 71.2 (70.5-72.8) 74.7 (69.3-79.6) 0.266 77.5 (61.55-89.16) 74.2 (68.34-79.49) 0.656
Preterm 9.2 (8.9-9.6) 17.3 (15.4-19.3) <0.001 22.8 (18.13-28.12) 16.0 (13.96-18.15) 0.005
Stillbirth 1.2 (1.1-1.3) 2.1 (1.5-2.9) 0.002 3.8 (1.92-6.71) 1.7 (1.07-2.61) 0.027
Congenital anomaly 1.8 (1.6-2.0) 1.4 (0.8-2.3) 0.437 3.1 (1.36-6.06) 0.9 (0.43-1.79) 0.032
Neonatal intensive care
unit admission
8.6 (8.3-9.0) 16.7 (14.8-15.7) <0.001 19.0 (14.62-24.07) 16.1 (14.08-18.31) 0.326
Data presented are mean (standard deviation) or percentage (95% confidence intervals).
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betes in these women.
The results for the final adjusted logistic regression
models and estimated odds ratios (ORs) are presented in
Table 4. Among all women, the factors significantly asso-
ciated with an increased risk of GDM included First Na-
tions ethnicity, age ≥ 35 years, weight ≥ 91 kg, pre-existing
hypertension, previous stillbirth, previous cesarean sec-
tion, and proteinuria. Age ≤ 17 years, rural residence,
smoking, and drug dependence were associated with a
lower risk of GDM. Among First Nations women, there
were significant associations with increased GDM risk for
age ≥ 35 years, weight ≥ 91 kg, previous stillbirth, previous
cesarean section, previous birthing of an infant that
was large for gestational age (LGA), and proteinuria.
Women ≤ 17 years and with drug dependence had a
lower risk of GDM.
Among all women, factors significantly associated with
an increased risk of pre-existing diabetes included First Na-
tions ethnicity, age ≥ 35 years, weight ≥ 91 kg, pre-existinghypertension, previous stillbirth, previous abortion, previ-
ous cesarean section, previous LGA infant, and proteinuria.
Age ≤ 17 years, having a previous small for gestational age
infant and alcohol consumption during pregnancy were as-
sociated with a lower risk of pre-existing diabetes. Among
First Nations women, there were significant associations
with increased pre-existing diabetes risk for the variables
age ≥ 35 years, weight ≥ 91 kg, previous stillbirth, previous
abortion, previous cesarean section, previous LGA infant,
and proteinuria. Being at an age ≤ 17 years conferred a
lower risk of pre-existing diabetes.
Discussion
Our large sample size over a 10-year period allowed for
analyses that indicated that having diabetes in pregnancy
(particularly pre-existing diabetes) compounds already
increased risks of adverse pregnancy outcomes for First
Nations women. The results of our study are unique in
that they are the first results that describe large-scale
trends over time for both pre-existing diabetes and
Table 3 Crude and age-adjusted prevalence of GDM and
pre-existing diabetes for all years (n = 427,058) and for
the most recent year of data (2009; n = 51,231), by
ethnicity, Alberta, Canada
First Nations Non-First
Nations
Rate ratio* P-value
Crude
GDM (all years) 4.3 (4.3-4.4) 3.8 (3.8-3.9) 1.1 <0.001
GDM (2009) 4.9 (4.2-4.6) 4.8 (4.6-5.0) 1.0 0.861
Pre-existing diabetes
(all years)
1.0 (1.0-1.1) 0.6 (0.6-0.7) 1.7 <0.001
Pre-existing diabetes
(2009)
1.1 (0.8-1.5) 0.7 (0.6-0.8) 1.6 0.006
Age-adjusted
GDM (all years) 6.1 (6.0-6.1) 3.8 (3.7-3.9) 1.6 <0.001
GDM (2009) 6.9 (6.8-6.9) 4.6 (4.6-4.7) 1.5 <0.001
Pre-existing diabetes
(all years)
1.5 (1.4-1.5) 0.6 (0.6-0.6) 2.5 <0.001
Pre-existing diabetes
(2009)
1.4 (1.3-1.4) 0.7 (0.6-0.7) 2.0 <0.001
Data presented are percentage (95% confidence interval).
GDM, gestational diabetes mellitus.
*First Nations-to-non-First Nations.
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Figure 1 Age-adjusted prevalence of diabetes in pregnancy over time
diabetes prevalence.
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prevalence was disproportionately higher among First
Nations women, we found that prevalence is growing
more rapidly among non-First Nations women. First Na-
tions women also suffer a greater than 2-fold higher
prevalence of pre-existing diabetes, which is likely con-
tributed to by early onset of type 2 diabetes in the prime
child-bearing years (i.e., twenties and thirties) [6]. How-
ever, the prevalence of pre-existing diabetes in preg-
nancy was generally stable over time amongst both
groups. An additional novel finding was that the epi-
demiological profile of diabetes in pregnancy in Alberta
does not appear to be as severe in comparison with
other provinces. Our study also provides new informa-
tion about previously unexplored maternal characteris-
tics and antenatal risk factors, and their associations
with diabetes in pregnancy.
This study is the first to calculate age-adjusted GDM
and pre-existing diabetes prevalence among a First Na-
tions population. Because advancing maternal age is a
risk factor for GDM, and the First Nations population
consists mostly of younger age groups [3,18], the resultsalence 
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Figure 2 Age-specific prevalence of diabetes for all years in pregnancy, by ethnic and age groups. Top = GDM prevalence, bottom=pre-existing
diabetes prevalence.
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ferences between First Nations and general populations.
Being of First Nations descent was independently associ-
ated with both GDM and pre-existing diabetes in preg-
nancy. Finally, in addition to risk factors identified in
previous studies [19-21], the results of this study indicate
that previous stillbirth, previous cesarean section, previ-
ous abortion (spontaneous or therapeutic), previous
LGA infant, and the presence of proteinuria are also in-
dependently associated with GDM and pre-existing dia-
betes in pregnancy in Indigenous women.
Values for several components of the total antepartum
risk score are higher in other First Nations populations.
These components include previous preterm birth [22],
smoking during pregnancy [23], fetal exposure to illicit
drugs [24], and stillbirth [25]. In the current study, preg-
nancy risk factors that showed the highest disparity be-
tween First Nations and non-First Nations women
included smoking anytime during pregnancy (3.2-fold),
the presence of anemia (3.8-fold), alcohol consumption
any time during pregnancy (6.1-fold), and drug depend-
ency (7.3-fold). It is likely that these factors contribute
to the observed poorer outcomes among First Nationsinfants, and interventions are clearly required to mitigate
these risks. The ethnic inequalities persisted in women
who only had diabetes in pregnancy. To our knowledge,
this was the first study to find adverse effects by First
Nations status among women with diabetes, associated
with high pre-existing weight, pre-existing hypertension,
proteinuria, anemia, stillbirth, smoking, alcohol con-
sumption, and drug dependency. All of these factors
were significantly more common among First Nations
women. This study is also the first to compare risk fac-
tors and pregnancy outcomes by diabetes status among
First Nations women only. Having diabetes (especially
pre-existing) clearly increased the risk of several adverse
pregnancy risk factors and outcomes, similar to previ-
ously reported results for non-Indigenous women [26].
This study confirmed the results of previous studies
that found a higher prevalence of GDM among First Na-
tions women [9,19,20,27]. However, the epidemiological
profile in Alberta did not seem to be as severe as in
other provinces. The crude First Nations GDM preva-
lence in Alberta (4.3%) was lower compared with First Na-
tions populations in other parts of Canada, such as
Manitoba (6.9%), Quebec (8.5%), and northwestern Ontario
Table 4 Multivariate predictors of GDM and pre-existing diabetes among all Albertan women and all First Nations
women, by ethnicity
All women First Nations
(n = 427,058) (n = 28,306)
Variable OR (95% CI)
for GDM
P-value OR (95% CI) for
pre-existing diabetes
P-value OR (95% CI)
for GDM
P-value OR (95% CI) for
pre-existing diabetes
P-value
First Nations ethnicity 1.47 (1.38-1.57) <0.001 1.73 (1.52-1.96) <0.001 – – – –
Rural residence 0.69 (0.66-0.73) <0.001 – – – – – –
Age≤ 17* 0.35 (0.28-0.45) <0.001 0.29 (0.16-0.52) <0.001 0.48 (0.34-0.67) <0.001 0.42 (0.18-0.94) 0.035
Age≥ 35* 2.34 (2.26-2.42) <0.001 1.57 (1.43-1.72) <0.001 2.81 (2.41-3.27) <0.001 2.23 (1.64-3.02) <0.001
Weight≥ 91 kg 2.51 (2.40-2.61) <0.001 2.31 (2.10-2.54) <0.001 2.93 (2.56-3.33) <0.001 3.25 (2.52-4.18) <0.001
Hypertension 1.63 (1.45-1.84) <0.001 4.45 (3.82-5.43) <0.001 – – 5.09 (3.03-8.58) <0.001
Previous stillbirth 1.96 (1.75-2.18) <0.001 2.56 (2.07-3.18) <0.001 1.76 (1.30-2.38) <0.001 3.05 (1.93-4.81) <0.001
Previous abortion – – 1.42 (1.23-1.64) <0.001 – – 1.58 (1.11-2.25) 0.012
Previous cesarean section 1.37 (1.32-1.43) <0.001 1.76 (1.61-1.94) <0.001 1.40 (1.20-1.63) <0.001 1.88 (1.41-2.47) <0.001
Previous small for
gestational age infant
– – 0.53 (0.29-0.96) 0.038 – – – –
Previous large for
gestational age infant
– – 2.79 (2.31-3.39) <0.001 2.58 (1.99-3.35) <0.001 3.23 (2.10-4.97) <0.001
Proteinuria 1.61 (1.48-1.76) <0.001 2.62 (2.23-3.08) <0.001 1.85 (1.40-2.44) <0.001 2.05 (1.26-3.32) 0.04
Smoker 0.90 (0.86-0.94) <0.001 – – – – – –
Drug dependant 0.51 (0.41-0.63) <0.001 – – 0.54 (0.39-0.74) <0.001 – –
Alcohol anytime – – 0.68 (0.50-0.93) 0.016 – – – –
Data presented are OR, odds ratios (95% confidence intervals);
GDM, gestational diabetes mellitus.
*Compared with age 18-34.
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crude rate ratio of 1.1 for GDM prevalence was also lower
in Alberta compared with the 1.8 and 2.9 ratios reported for
women in the provinces of Saskatchewan and Manitoba,
respectively [19,20]. Similarly, we have recently found
that rate ratios for overall diabetes incidence and preva-
lence are also lower in Alberta compared with other
provinces [7]. The results of our study cannot explain
provincial differences, but we speculate they may be re-
lated to socio-economic differences, and/or a combin-
ation of provincial and community-based programming
targeting awareness such as the provincial Alberta Dia-
betes Strategy, the federally funded Aboriginal Diabetes
Initiative, or changes in clinical practice. Future studies
are needed to uncover reasons for regional variations,
and should include age-adjustments for more inform-
ative comparisons across ethnic groups.
GDM prevalence is increasing in many populations
worldwide [28], and this pattern is also present among
non-First Nations Albertan women. The increasing age of
pregnant non-First Nations women and an influx of minor-
ity immigrants likely have contributed to this increase in
prevalence [20,29]. The situation does not seem as clear
among Indigenous populations, because prevalence is not
increasing significantly in Alberta First Nations women.
This is consistent with our article on overall diabetesprevalence in Alberta [7], which reported that overall dia-
betes prevalence is increasing more rapidly among the non-
First Nations population. One US study found that GDM
prevalence among American Indian women increased from
3.1% to 4.1% during 1989–2000 [30]. However, studies
among Aborigines in Australia have found that prevalence
values are stable or even decreasing over time [31,32].
Liu et al [33] reported a higher pre-existing diabetes
prevalence in Ontario First Nations women (3.9%) com-
pared with their non-First Nations counterparts (1.8%).
This result is consistent with our results and with the in-
creased numbers of young women of child-bearing age
with type 2 diabetes that we and others have documented
in First Nations populations [6,7]. As with GDM, pre-
existing diabetes prevalence is lower among Alberta
First Nations (1.0% crude) compared with Ontario First
Nations women.
To our knowledge, this study is the first to describe
trends in pre-existing diabetes in pregnancy over time in
an Indigenous population. The stability of prevalence in
the First Nations and non-First Nations populations is
surprising and encouraging, because the prevalence of
pre-existing diabetes in pregnancy is increasing world-
wide [34] and overall diabetes prevalence appears to be
increasing in both the First Nations and non-First Na-
tions populations [7].
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cannot be generalized to non-registered First Nations indi-
viduals or to Métis individuals. These individuals could
not be identified and were included in the non-First Na-
tions population group. Also, the completeness of cover-
age of the First Nations identification could not be
determined, so the observed ethnic (First Nations vs. non-
First Nations) disparities could have been underestimated.
Screening for diabetes in early pregnancy is often not per-
formed (personal observation, E.L.T.) even though it is
recommended for women with multiple risk factors [13].
Therefore, it is also likely that some First Nations women
with pre-existing diabetes were not diagnosed, and were
later classified as having GDM. This error would under-
estimate the magnitude of the findings of worse outcomes
with pre-existing diabetes than with GDM. Whether the
recorded pre-existing diabetes cases were type 1 or type 2
diabetes could not be discerned from the administrative
data. Clinical experience suggests that most diabetes in
young First Nations women is type 2 diabetes, but the
prevalence of type 2 diabetes amongst non-First Nations
populations (as we defined them) is also increasing. We
believe that this change is due to obesity, immigration,
and the inclusion of non-registered Indigenous persons.
Further research is needed to determine the specific con-
tributions of type 1 and type 2 diabetes, but glucose control
is equally important to perinatal outcomes regardless the
type of pre-existing diabetes. The degree to which diabetes
was successfully managed (glucose control, hemoglobin
A1c) also could not be determined for the study popula-
tion. Finally, the contribution of other potential contextual
predictors (e.g., healthcare access, lifestyle, overweight/
obesity, social environment, income) to the logistic regres-
sion models could not be assessed.
Conclusion
First Nations women suffer a higher prevalence of dia-
betes in pregnancy and more adverse pregnancy out-
comes, but the prevalence in Alberta does not appear to
be as high as it is in other provinces. Future studies are
needed to uncover reasons for regional variations and
should use age-adjustment for more informative com-
parisons across ethnic groups. Future and ongoing mon-
itoring of diabetes prevalence in pregnancy, information
on pregnancy outcomes, and epidemiological data on
diabetes in pregnancy among other Indigenous popula-
tions (Métis, Inuit, non-registered Indigenous women)
will be necessary. More complex and inclusive studies
should be used to assess the contribution of other poten-
tial contextual predictors (e.g., healthcare access, lifestyle,
social environment, income, medical management).
Our findings should allow government and healthcare
organizations to develop policy and plan healthcare de-
livery, and to evaluate efforts and assess their cost-effectiveness, so that perinatal care in this population
can be improved.
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